Gene silencing by cell-penetrating, sequence-selective and nucleic-acid hydrolyzing antibodies

Nucleic Acids Research

Volumn 38, Issue 5, 2009, Pages 1596-1609

  Lee, Woo Ram ^a   Jang, Ji Young ^b   Kim, Jeong Sun ^c   Kwon, Myung Hee ^b   Kim, Yong Sung ^a  

^a Ajou University   (South Korea)

^b Ajou University School of Medicine   (South Korea)

^c Chonnam National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; MESSENGER RNA; NUCLEIC ACID ANTIBODY; PROTEIN ANTIBODY; PROTEIN DERIVATIVE; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; CATALYTIC ANTIBODY; HER2 PROTEIN, HUMAN; IMMUNOGLOBULIN LIGHT CHAIN; SINGLE STRANDED DNA;

APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL; CONTROLLED STUDY; CYTOSOL; GENE SEQUENCE; GENE SILENCING; GENE TARGETING; HUMAN; HUMAN CELL; HYDROLYSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN TARGETING; PROTEIN VARIANT; RNA SEQUENCE; CHEMISTRY; DRUG ANTAGONISM; GENE LIBRARY; GENETICS; IMMUNOGLOBULIN VARIABLE REGION; METABOLISM; RNA INTERFERENCE; TUMOR CELL LINE;

ANTIBODIES, CATALYTIC; APOPTOSIS; BASE SEQUENCE; CELL LINE, TUMOR; CYTOSOL; DNA, SINGLE-STRANDED; GENE KNOCKDOWN TECHNIQUES; GENE LIBRARY; HUMANS; HYDROLYSIS; IMMUNOGLOBULIN LIGHT CHAINS; IMMUNOGLOBULIN VARIABLE REGION; RECEPTOR, ERBB-2; RNA INTERFERENCE; RNA, MESSENGER;

EID: 77950499389     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkp1145     Document Type: Article

References (41)

1. Scherer, L.J. and Rossi, J.J. (2003) Approaches for the sequence-specific knockdown of mRNA. Nat. Biotechnol., 21, 1457-1465.
2. Tafech, A., Bassett, T., Sparanese, D. and Lee, C.H. (2006) Destroying RNA as a therapeutic approach. Curr. Med. Chem., 13, 863-881
3. Carthew, R.W. and Sontheimer, E.J. (2009) Origins and Mechanisms of miRNAs and siRNAs. Cell, 136, 642-655
4. Cullen, B.R. (2006) Enhancing and confirming the specificity of RNAi experiments. Nat. Methods, 3, 677-681
5. Makarov, A.A. and Ilinskaya, O.N. (2003) Cytotoxic ribonucleases: molecular weapons and their targets. FEBS Lett., 540, 15-20
6. Avrameas, A., Ternynck, T., Nato, F., Buttin, G. and Avrameas, S. (1998) Polyreactive anti-DNA monoclonal antibodies and a derived peptide as vectors for the intracytoplasmic and intranuclear translocation of macromolecules. Proc. Natl Acad. Sci. USA, 95, 5601-5606
7. Jang, J.Y., Jeong, J.G., Jun, H.R., Lee, S.C., Kim, J.S., Kim, Y.S. and Kwon, M.H. (2009) A nucleic acid-hydrolyzing antibody penetrates into cells via caveolae-mediated endocytosis, localizes in the cytosol and exhibits cytotoxicity. Cell Mol. Life Sci., 66, 1985-1997
8. Dow-Tien, C., Yuan-Jhih, T. and Alan, L. (2008) Creating a ribonuclease T-tat that preferentially recognizes and hydrolyzes HIV-1 TAR RNA in vitro and in vivo. Nucleic Acids Res., 36, 963-969
9. Melekhovets, Y.F. and Joshi, S. (1996) Fusion with an RNA binding domain to confer target RNA specificity to an RNase: design and engineering of Tat-RNase H that specifically recognizes and cleaves HIV-1 RNA in vitro. Nucleic Acids Res., 24, 1908-1912
10. Heng, B.C. and Cao, T. (2005) Making cell-permeable antibodies (Transbody) through fusion of protein transduction domains (PTD) with single chain variable fragment (scFv) antibodies: potential advantages over antibodies expressed within the intracellular environment (Intrabody). Med. Hypotheses, 64, 1105-1108
11. Muller, S., Zhao, Y., Brown, T.L., Morgan, A.C. and Kohler, H. (2005) TransMabs: cell-penetrating antibodies, the next generation. Expert Opin. Biol. Ther., 5, 237-241
12. Kim, D.S., Lee, S.H., Kim, J.S., Lee, S.C., Kwon, M.H. and Kim, Y.S. (2009) Generation of humanized anti-DNA hydrolyzing catalytic antibodies by complementarity determining region grafting. Biochem. Biophys. Res. Commun., 379, 314-318
13. Kim, Y.R., Kim, J.S., Lee, S.H., Lee, W.R., Sohn, J.N., Chung, Y.C., Shim, H.K., Lee, S.C., Kwon, M.H. and Kim, Y.S. (2006) Heavy and light chain variable single domains of an anti-DNA binding antibody hydrolyze both double- and single-stranded DNAs without sequence specificity. J. Biol. Chem., 281, 15287-15295.
14. Lee, H.W., Lee, S.H., Park, K.J., Kim, J.S., Kwon, M.H. and Kim, Y.S. (2006) Construction and characterization of a pseudoimmune human antibody library using yeast surface display. Biochem. Biophys. Res. Commun., 346, 896-903
15. Park, K.J., Lee, S.H., Kim, T.I., Lee, H.W., Lee, C.H., Kim, E.H., Jang, J.Y., Choi, K.S., Kwon, M.H. and Kim, Y.S. (2007) A human scFv antibody against TRAIL receptor 2 induces autophagic cell death in both TRAIL-sensitive and TRAIL-resistant cancer cells. Cancer Res., 67, 7327-7334
16. Lee, S.H., Carpenter, J.F., Chang, B.S., Randolph, T.W. and Kim, Y.S. (2006) Effects of solutes on solubilization and refolding of proteins from inclusion bodies with high hydrostatic pressure. Protein Sci., 15, 304-313
17. Park, S.Y., Lee, W.R., Lee, S.C., Kwon, M.H., Kim, Y.S. and Kim, J.S. (2008) Crystal structure of single-domain VL of an anti-DNA binding antibody 3D8 scFv and its active site revealed by complex structures of a small molecule and metals. Proteins, 71, 2091-2096
18. Townsend, H.L., Jha, B.K., Han, J.Q., Maluf, N.K., Silverman, R.H. and Barton, D.J. (2008) A viral RNA competitively inhibits the antiviral endoribonuclease domain of RNase L. RNA, 14, 1026-1036
19. Sung, E.S., Park, K.J., Lee, S.H., Jang, Y.S., Park, S.K., Park, Y.H., Kwag, W.J., Kwon, M.H. and Kim, Y.S. (2009) A novel agonistic antibody to human death receptor 4 induces apoptotic cell death in various tumor cells without cytotoxicity in hepatocytes. Mol. Cancer Ther., 8, 2276-2285
20. Guenin, S., Mauriat, M., Pelloux, J., Van Wuytswinkel, O., Bellini, C. and Gutierrez, L. (2009) Normalization of qRT-PCR data: the necessity of adopting a systematic, experimental conditions- specific, validation of references. J. Exp. Bot., 60, 487-493
21. Hackel, B.J., Kapila, A. and Wittrup, K.D. (2008) Picomolar affinity fibronectin domains engineered utilizing loop length diversity, recursive mutagenesis, and loop shuffling. J. Mol. Biol., 381, 1238-1252
22. Faltus, T., Yuan, J., Zimmer, B., Kramer, A., Loibl, S., Kaufmann, M. and Strebhardt, K. (2004) Silencing of the HER2/neu gene by siRNA inhibits proliferation and induces apoptosis in HER2/neu-overexpressing breast cancer cells. Neoplasia, 6, 786-795
23. Choudhury, A., Charo, J., Parapuram, S.K., Hunt, R.C., Hunt, D.M., Seliger, B. and Kiessling, R. (2004) Small interfering RNA (siRNA) inhibits the expression of the Her2/neu gene, upregulates HLA class I and induces apoptosis of Her2/neu positive tumor cell lines. Int. J. Cancer, 108, 71-77
24. Blackburn, P., Wilson, G. and Moore, S. (1977) Ribonuclease inhibitor from human placenta. Purification and properties. J. Biol. Chem., 252, 5904-5910
25. Rana, T.M. (2007) Illuminating the silence: understanding the structure and function of small RNAs. Nat. Rev. Mol. Cell Biol., 8, 23-36
26. Duchardt, F., Fotin-Mleczek, M., Schwarz, H., Fischer, R. and Brock, R. (2007) A comprehensive model for the cellular uptake of cationic cell-penetrating peptides. Traffic, 8, 848-866
27. Wang, T., Zhao, J., Ren, J.L., Zhang, L., Wen, W.H., Zhang, R., Qin, W.W., Jia, L.T., Yao, L.B., Zhang, Y.Q. et al. (2007) Recombinant immunoproapoptotic proteins with furin site can translocate and kill HER2-positive cancer cells. Cancer Res., 67, 11830-11839
28. Manikandan, J., Pushparaj, P.N. and Melendez, A.J. (2007) Protein i: interference at protein level by intrabodies. Front Biosci., 12, 1344-1352
29. Tanaka, T., Williams, R.L. and Rabbitts, T.H. (2007) Tumour prevention by a single antibody domain targeting the interaction of signal transduction proteins with RAS. Embo J., 26, 3250-3259
30. Ye, J.D., Tereshko, V., Frederiksen, J.K., Koide, A., Fellouse, F.A., Sidhu, S.S., Koide, S., Kossiakoff, A.A. and Piccirilli, J.A. (2008)Synthetic antibodies for specific recognition and crystallization of structured RNA. Proc. Natl Acad. Sci. USA, 105, 82-87
31. Bobeck, M.J., Rueda, D., Walter, N.G. and Glick, G.D. (2007) Structural modeling of sequence specificity by an autoantibody against single-stranded DNA. Biochemistry, 46, 6753-6765
32. Cerutti, M.L., Centeno, J.M., Goldbaum, F.A. and de Prat-Gay, G. (2001) Generation of sequence-specific, high affinity anti-DNA antibodies. J. Biol. Chem., 276, 12769-12773
33. Mandell, J.G. and Barbas, C.F. 3rd. (2006) Zinc Finger Tools: custom DNA-binding domains for transcription factors and nucleases. Nucleic Acids Res., 34, W516-W523
34. Auweter, S.D., Oberstrass, F.C. and Allain, F.H. (2006) Sequence-specific binding of single-stranded RNA: is there a code for recognition? Nucleic Acids Res., 34, 4943-4959
35. Lustig, B., Arora, S. and Jernigan, R.L. (1997) RNA base-amino acid interaction strengths derived from structures and sequences. Nucleic Acids Res., 25, 2562-2565
36. Yanase, K. and Madaio, M.P. (2005) Nuclear localizing anti-DNA antibodies enter cells via caveoli and modulate expression of caveolin and p53. J. Autoimmun., 24, 145-151
37. Kozyr, A.V., Sashchenko, L.P., Kolesnikov, A.V., Zelenova, N.A., Khaidukov, S.V., Ignatova, A.N., Bobik, T.V., Gabibov, A.G., Alekberova, Z.S., Suchkov, S.V. et al. (2002) Anti-DNA autoantibodies reveal toxicity to tumor cell lines. Immunol. Lett., 80, 41-47
38. Rivadeneyra-Espinoza, L. and Ruiz-Arguelles, A. (2006) Cell-penetrating anti-native DNA antibodies trigger apoptosis through both the neglect and programmed pathways. J. Autoimmun., 26, 52-56
39. Ruiz-Arguelles, A., Rivadeneyra-Espinoza, L. and Alarcon-Segovia, D. (2003) Antibody penetration into living cells: pathogenic, preventive and immuno-therapeutic implications. Curr. Pharm. Des., 9, 1881-1887
40. Avrameas, A., Gasmi, L. and Buttin, G. (2001) DNA and heparin alter the internalization process of anti-DNA monoclonal antibodies according to patterns typical of both the charged molecule and the antibody. J. Autoimmun., 16, 383-391
41. Zack, D.J., Stempniak, M., Wong, A.L., Taylor, C. and Weisbart, R.H. (1996) Mechanisms of cellular penetration and nuclear localization of an anti-double strand DNA autoantibody. J. Immunol., 157, 2082-2088